Taspoglutide

Basic Description

Structure and function:
Tasirolitide is a synthetic peptide drug that is a glucagon-like peptide-1 (GLP-1) receptor agonist.
It is composed of 39 amino acids, which have been chemically modified to prolong its half-life in the body.
By activating the GLP-1 receptor, taseroglutide can promote insulin secretion from pancreatic β cells and inhibit the release of glucagon, thereby lowering blood glucose levels.
Tasirolid also slows gastric emptying and reduces appetite, which can help control body weight.
In vitro and in vivo studies:
In in vitro experiments, tasirolid significantly increased insulin secretion and inhibited glucagon secretion.
In vivo experiments, tasirolitin can effectively reduce postprandial blood glucose levels and improve glycated hemoglobin (HbA1c) levels in patients with type 2 diabetes.
Clinical trials have shown that tasirolitinib can reduce the risk of cardiovascular events while lowering blood sugar.

​ ​Three-letter sequence​

​ ​Single letter sequence​

CAS Number

Molecular formula

Molecular weight

purity

>98%

form

Lyophilized powder

Storage conditions

Store at -20°C/-80°C away from light